Patents by Inventor Vincent Santucci

Vincent Santucci has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of NK.sub.1 receptor antagonists for preparing cardio-regulatory drugs
    Patent number: 5852044
    Abstract: The invention relates to the use of NK.sub.1 receptor antagonists for the preparation of drugs with a cardioregulatory action, intended in particular for controlling heart rate disorders and cardiac dysrhythtmia.
    Type: Grant
    Filed: April 21, 1997
    Date of Patent: December 22, 1998
    Assignee: Sanofi
    Inventors: Christiane Gueudet, Vincent Santucci, Philippe Soubrie
  • Hexahydroazepine derivatives, a process for their preparation
    Patent number: 5296596
    Abstract: The present invention relates to hexahydroazepine derivatives of formula ##STR1## in which: A=--CO--CH.sub.2 --, --CH(OH)--CH.sub.2 --; --CH.sub.2 --CH.sub.2 --; --CH.dbd.CH--; --C.tbd.C--;X=H or a halogen;Y=cyclohexyl or, when X is H, phenyl.It likewise relates to the salts of the said derivatives, to a process for the preparation of these and to the pharmaceutical compositions containing them, more particularly as antipsychotic agents.
    Type: Grant
    Filed: April 14, 1993
    Date of Patent: March 22, 1994
    Assignee: ELF SANOFI
    Inventors: Serge Lavastre, Jean-Pierre Maignan, Raymond Paul, Martine Poncelet, Vincent Santucci
  • Hexahydroazepine derivatives and pharmaceutical compositions containing them
    Patent number: 5231092
    Abstract: The present invention relates to hexahydroazepine derivatives of formula ##STR1## in which: A=--CO--CH.sub.2 --, --CH(OH--CH.sub.2 --; --CH.sub.2 --CH.sub.2 --CH.sub.2 --;--CH.dbd.CH--; --C.tbd.C--;X=H or a halogen;Y=cylcohexyl or, when X is H, phenyl.It likewise relates to the salts of the said derivatives, to a process for the preparation of these and to the pharmaceutical compositions containing them, more particularly as antipsychotic agents.
    Type: Grant
    Filed: June 13, 1991
    Date of Patent: July 27, 1993
    Assignee: Sanofi
    Inventors: Serge Lavastre, Jean-Pierre Maignan, Raymond Paul, Martine Poncelet, Vincent Santucci